puberty; precocious, central

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Puberty; Precocious, Central Trial (Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide)

Not yet recruiting
  • Puberty; Precocious, Central
  • Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide
  • (no location specified)
Aug 5, 2022